Susquehanna International Group, LLP Kazia Therapeutics LTD Call Options Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.19 - $1.24 $2,736 - $17,856
14,400 New
14,400 $6,000
Q2 2021

Aug 11, 2021
BUY
$9.1 - $14.71 $30,940 - $50,014
3,400 Added 10.06%
37,200 $367,000
Q1 2021

May 17, 2021
BUY
$8.98 - $12.86 $76,330 - $109,310
8,500 Added 33.6%
33,800 $419,000
Q4 2020

Feb 16, 2021
BUY
$5.61 - $13.47 $141,933 - $340,791
25,300 New
25,300 $219,000

Others Institutions Holding KZIA

# of Institutions
21
Shares Held
2.13M
Call Options Held
93.2K
Put Options Held
0
View Full List

About KAZIA THERAPEUTICS LTD

KZIA Quotes by TradingView
  • Ticker KZIA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,111,300
  • Market Cap $47M
  • Description
  • Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...
More about KZIA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email